Crossmark

Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients

Crossref DOI link: https://doi.org/10.1016/j.medcle.2024.04.015

Published Print: 2024-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Armestar, Fernando

Vitoria Rubio, Sara

Ojanguren Sabán, Isabel

Coll-Cantí, Jaume

Perez Molto, Hipólito
License Information

Text and Data Mining valid from 2024-10-01

Text and Data Mining valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01
More Information

This article is maintained by: Elsevier

Article Title: Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2024.04.015

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2024.04.025

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.